Patient and treatment characteristics at first presentation | Number | Percent (range) |
---|---|---|
Male | 35 | 65 |
Female | 19 | 35 |
Median age (years) | 59 | (33–81) |
Tumor site | ||
Larynx | 6 | 11 |
Oropharyngeala | 18 | 33 |
Nasopharyngeal | 1 | 2 |
Hypopharyngeal | 5 | 9 |
Oral cavity | 17 | 31 |
Unknown primary | 2 | 4 |
Sino/nasal | 3 | 6 |
Salivary gland | 2 | 4 |
Histology | ||
Squamous cell carcinoma | 46 | 85 |
Adenoid cystic carcinoma | 5 | 9 |
Otherb | 3 | 6 |
Tumor Stage | ||
I | 5 | 9 |
II | 11 | 20 |
III | 7 | 13 |
IVa | 28 | 52 |
IVb | 3 | 6 |
T-stage | ||
0 | 2 | 4 |
1 | 9 | 17 |
2 | 22 | 41 |
3 | 4 | 7 |
4 | 17 | 31 |
Median treatment dose (Gy) | 68 | (60–79) |